Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steven H. Kirtland is active.

Publication


Featured researches published by Steven H. Kirtland.


Clinics in Chest Medicine | 1997

TREATMENT WITH CORTICOSTEROIDS

Richard H. Winterbauer; Steven H. Kirtland; David E. Corley

Oral corticosteroids remain the cornerstone therapy for sarcoidosis. Critical clinical decisions include selecting the patient who should be treated, dose and duration of therapy, and accurate analysis of the anticipated benefits and potential side effects for the individual patient. The treatment of pulmonary and cardiac sarcoidosis is emphasized and the role of inhaled corticosteroids in the treatment of pulmonary sarcoidosis is reviewed.


Aviation, Space, and Environmental Medicine | 2013

Altitude exposures during commercial flight: a reappraisal.

Neil B. Hampson; David A Kregenow; Anne M Mahoney; Steven H. Kirtland; Kathleen L Horan; James R. Holm; Anthony J. Gerbino

BACKGROUND Hypobaric hypoxia during commercial air travel has the potential to cause or worsen hypoxemia in individuals with pre-existing cardiopulmonary compromise. Knowledge of cabin altitude pressures aboard contemporary flights is essential to counseling patients accurately about flying safety. The objective of the study was to measure peak cabin altitudes during U.S. domestic commercial flights on a variety of aircraft. METHODS A handheld mountaineering altimeter was carried by the investigators in the plane cabin during commercial air travel and peak cabin altitude measured. The values were then compared between aircraft models, aircraft classes, and distances flown. RESULTS The average peak cabin altitude on 207 flights aboard 17 different aircraft was 6341 +/- 1813 ft (1933 m +/- 553 m), significantly higher than when measured in a similar fashion in 1988. Peak cabin altitude was significantly higher for flights longer than 750 mi (7085 +/- 801 ft) compared to shorter flights (5160 +/- 2290 ft/1573 +/- 698 m). Cabin altitude increased linearly with flight distance for flights up to 750 mi in length, but was independent of flight distance for flights exceeding 750 mi. Peak cabin altitude was less than 5000 ft (1524 m) in 70% of flights shorter than 500 mi. Peak cabin altitudes greater than 8000 ft (2438 m) were measured on approximately 10% of the total flights. CONCLUSIONS Peak cabin altitude on commercial aircraft flights has risen over time. Cabin altitude is lower with flights of shorter distance. Physicians should take these factors into account when determining an individuals need for supplemental oxygen during commercial air travel.


Journal of Clinical Oncology | 2014

Effect of a multidisciplinary cancer conference for thoracic malignancies on patient care management.

Henner M. Schmidt; John M. Roberts; Artur M. Bodnar; Steven H. Kirtland; Sonia Kunz; Sheraz R. Markar; Donald E. Low

112 Background: Treatment of thoracic cancers frequently involve multiple subspecialties thus treatment decisions are typically best facilitated in multidisciplinary tumor boards (MTB). This approach should facilitate and improve treatment decision making, standardize staging and therapeutic decisions and improve outcomes. In this study we analyze the evolution in staging and treatment decision making associated with presentation at MTB. Methods: Retrospective review of all patients with lung or esophageal cancer presented at our weekly MTB from June 1, 2010 to September 30, 2012. All providers submitting patients to tumor board recorded their current treatment plan prior to presentation. The physician’s plan was then compared to the tumor board’s final recommendation. Changes made were graded according to degree of magnitude as minor, moderate or major change. Minor changes included changes in diagnostic imaging. Moderate changes involved modifications in the type of invasive staging or biopsy procedures...


Archive | 2002

Chronic Bacterial Pneumonia

Steven H. Kirtland; Richard H. Winterbauer

Chronic bacterial pneumonias are more common than previously recognized. They often present in the absence of fever and purulent sputum production. Although cough is the most common symptom, constitutional symptoms such as fatigue and weight loss are also frequent. H. influenzae and are the predominant bacterial pathogens in patients both with and without predisposing illness. Sixty-five percent of patients with chronic bacterial pneumonia will have a recognizable predisposing disease. The roentgenographic appearance is variable and nonspecific. Bronchoscopic evaluation is essential. Short courses of therapy have a high incidence of recurrence, despite initial symptomatic improvement. Thus, successful treatment requires prolonged therapy.


Chest | 1997

The Diagnosis of Ventilator-Associated Pneumonia : A Comparison of Histologic, Microbiologic, and Clinical Criteria

Steven H. Kirtland; David E. Corley; Richard H. Winterbauer; Steven C. Springmeyer; Kenneth R. Casey; Neil B. Hampson; David F. Dreis


Chest | 1995

Changes in Pulmonary Function Test Results After 1 Year of Therapy as Predictors of Survival in Patients With Idiopathic Pulmonary Fibrosis

Daniel Hanson; Richard H. Winterbauer; Steven H. Kirtland; Rae Wu


Chest | 1997

Reproducibility of the Histologic Diagnosis of Pneumonia Among a Panel of Four Pathologists: Analysis of a Gold Standard

David E. Corley; Steven H. Kirtland; Richard H. Winterbauer; Samuel P. Hammar; David H. Dail; Donald E. Bauermeister; John W. Bolen


The Journal of Thoracic and Cardiovascular Surgery | 2012

Repair of giant paraesophageal hernias routinely produces improvement in respiratory function.

Philip W. Carrott; Jean Hong; MadhanKumar Kuppusamy; Steven H. Kirtland; Richard P. Koehler; Donald E. Low


Chest | 1994

A Clinical Profile of Chronic Bacterial Pneumonia: Report of 115 Cases

Steven H. Kirtland; Richard H. Winterbauer; David F. Dreis; Neely E. Pardee; Steven C. Springmeyer


The Annals of Thoracic Surgery | 2015

Thoracic Multidisciplinary Tumor Board Routinely Impacts Therapeutic Plans in Patients With Lung and Esophageal Cancer: A Prospective Cohort Study

Henner M. Schmidt; John M. Roberts; Artur M. Bodnar; Sonia Kunz; Steven H. Kirtland; Richard P. Koehler; Michal Hubka; Donald E. Low

Collaboration


Dive into the Steven H. Kirtland's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

David E. Corley

Virginia Mason Medical Center

View shared research outputs
Top Co-Authors

Avatar

Donald E. Low

Virginia Mason Medical Center

View shared research outputs
Top Co-Authors

Avatar

Steven C. Springmeyer

Virginia Mason Medical Center

View shared research outputs
Top Co-Authors

Avatar

Artur M. Bodnar

Virginia Mason Medical Center

View shared research outputs
Top Co-Authors

Avatar

David F. Dreis

Virginia Mason Medical Center

View shared research outputs
Top Co-Authors

Avatar

Henner M. Schmidt

Virginia Mason Medical Center

View shared research outputs
Top Co-Authors

Avatar

John M. Roberts

Virginia Mason Medical Center

View shared research outputs
Top Co-Authors

Avatar

MadhanKumar Kuppusamy

Virginia Mason Medical Center

View shared research outputs
Top Co-Authors

Avatar

Michal Hubka

Virginia Mason Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge